-
July 19-20: Multiple Imputation Methods for Addressing Missing Data in Health Economic Evaluation - Virtual
-
July 26-27: Introduction to Modeling Methods - Virtual
-
Data Privacy and Digital Health: The Manufacturers/Payers Perspective
-
Stakeholder Engagement in Value Assessment
-
August 16-17: Model Calibration in R- Virtual
-
August 31-September 1: Risk-Sharing/Performance-Based Arrangements for Drugs and Other Medical Products- Virtual
-
September 7: Budget Impact Analysis I: A 6-Step Approach- Virtual
-
Differentiating Between Patient Preferences, Patient Reported Outcomes and Patient Engagement
-
An Introduction to Network Meta-Analysis
-
How Can Society Sustainably Benefit From Biosimilars? Global Learnings and Policy Recommendations for Australia
-
Clinical Outcome Assessments in the Asia-Pacific Region: Strategy & Implementation
-
September 19-21: Budget Impact Analysis II: Applications and Design Issues- Virtual
-
Virtual ISPOR Asia Pacific Summit 2022
Virtual ISPOR Asia Pacific 2022, will offer a robust scientific program focused on in-depth studies of the current state of HEOR in the region, and how HEOR can support health systems confronting defining issues like healthcare quality, access and affordability in the Asia Pacific.
-
Network Meta-Analysis - Special Topics
-
September 27-28: Pharmacoeconomic Modeling–Applications- Virtual
-
Signal - Episode 8
-
On the Validity of Statistical Analyses with Privacy-Preserving Synthetic Data
-
Fit for Local Context? Establishing or Improving Deliberative Processes for HTA
-
Availability and Access to Innovative Therapies in Latin America
-
Souring On SUCRAs: When Treatment Ranking Goes Wrong